Skip to main content
Joseph Drabick, MD, Oncology, Hershey, PA, Penn State Milton S. Hershey Medical Center

JosephJDrabickMD

Oncology Hershey, PA

Professor of Medicine, Hematology-Oncology Penn State Hershey Cancer Institute

Dr. Drabick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Drabick's full profile

Already have an account?

Summary

  • Dr. Joseph Drabick is an oncologist in Hershey, PA and is affiliated with Penn State Milton S. Hershey Medical Center. He received his medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 34 years. He is experienced in immunotherapy, hematology, infectious diseases, oncology, and emergency medicine.

Education & Training

  • National Capital Consortium
    National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1997 - 2000
  • National Capital Consortium
    National Capital ConsortiumFellowship, Infectious Disease, 1986 - 1988
  • National Capital Consortium
    National Capital ConsortiumResidency, Internal Medicine, 1983 - 1986
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1983

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1986 - 2024
  • MD State Medical License
    MD State Medical License 1989 - 2004
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Infectious Disease
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • FACP, FIDSI
  • US Army Legion of Merit United States Army, 2004

Publications & Presentations

PubMed

Journal Articles

  • Original Contribution Mitotic Activity in Non-Invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to the Contemporary Two...  
    Augustyna Gogoj, Suzanne B Merrill, Monika Joshi, Sheldon Holder, Joshua I Warrick, Matthew Kaag, Jay D Raman, Joseph Drabick, ScienceDirect

Press Mentions

  • Need for a Personalized Approach for Muscle Invasive Bladder Cancer: Role of Tumor Biology in Response to Neoadjuvant Chemotherapy
    Need for a Personalized Approach for Muscle Invasive Bladder Cancer: Role of Tumor Biology in Response to Neoadjuvant ChemotherapyDecember 4th, 2018
  • Metastatic Melanoma Patients May Benefit from Beta Blockers
    Metastatic Melanoma Patients May Benefit from Beta BlockersJanuary 22nd, 2018
  • Existing Drug May Improve Melanoma Survival
    Existing Drug May Improve Melanoma SurvivalJanuary 9th, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations